Anti-HIV effects of chloroquine: mechanisms of inhibition and spectrum of activity
- 1 November 2001
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in AIDS
- Vol. 15 (17), 2221-2229
- https://doi.org/10.1097/00002030-200111230-00002
Abstract
To investigate the mechanisms and spectrum of the anti-HIV activity of chloroquine. MT-4 cells or peripheral blood mononuclear cells were infected with X4, R5 or R5/X4 HIV-1 strains from clades A–E and HIV-2. The cells were then treated with clinically relevant and achievable chloroquine concentrations (i.e. 0–12.5 μM), so as to determine the EC50. The effects of chloroquine on reverse transcription and integration were tested using a replication-defective reporter HIV-1 construct (pRRL.sin.hPGK.GFP). The effects of the drug on the viral envelope were assessed by syncytium assays and immunoprecipitation, using antibodies to different epitopes of gp120. In de-novo infected MT-4 cells, chloroquine selectively inhibited HIV-1 IIIB replication but not pRRL.sin.hPGK.GFP. In chronically HIV-1-infected H9 IIIB cells, chloroquine decreased the infectivity of the newly produced virus and the ability of these cells to form syncytia in co-culture with MT-2 cells. These effects were associated with structural changes in the gp120 glycoprotein, such as a reduction of reactivity with antibodies directed against the glycosylated 2G12 epitope. Although affecting a variable target such as gp120, chloroquine was capable of inhibiting X4, R5 and R5/X4 primary HIV-1 isolates from subtypes A, B, C, D, E and HIV-2. At clinically achievable concentrations chloroquine inhibits HIV-1 post-integrationally by affecting newly produced viral envelope glycoproteins, and the drug has broad-spectrum anti-HIV-1 and HIV-2 activity.This publication has 29 references indexed in Scilit:
- Cyanovirin-N, a Potent Human Immunodeficiency Virus-Inactivating Protein, Blocks both CD4-Dependent and CD4-Independent Binding of Soluble gp120 (sgp120) to Target Cells, Inhibits sCD4-Induced Binding of sgp120 to Cell-Associated CXCR4, and Dissociates Bound sgp120 from Target CellsAntimicrobial Agents and Chemotherapy, 2001
- Sequence Specificity of the Human Immunodeficiency Virus Type 2 (HIV-2) Long Terminal Repeat U3 Regionin VivoAllows Subtyping of the Principal HIV-2 Viral Subtypes A and BAIDS Research and Human Retroviruses, 2001
- Chloroquine Exerts an Additive in Vitro Anti-HIV Type 1 Effect When Associated with Didanosine and HydroxyureaAIDS Research and Human Retroviruses, 1999
- Inhibition of HIV-1 replication by hydroxychloroquine: mechanism of action and comparison with zidovudineClinical Therapeutics, 1996
- Clinical Pharmacokinetics and Metabolism of ChloroquineClinical Pharmacokinetics, 1996
- Inhibition of HIV-1 Tat-Mediated Transactivation by Quinacrine and ChloroquineBiochemical and Biophysical Research Communications, 1996
- Hydroxychloroquine treatment of patients with human immunodeficiency virus type 1Clinical Therapeutics, 1995
- Thiamine Disulfide as a Potent Inhibitor of Human Immunodeficiency Virus (Type-1) ProductionBiochemical and Biophysical Research Communications, 1994
- Detection of Simian Immunodeficiency Virus and Human Immunodeficiency Virus Type 2 Capsid Antigens by a Monoclonal Antibody-Based Antigen Capture AssayAIDS Research and Human Retroviruses, 1993
- Inhibition of Human Immunodeficiency Virus Infectivity by ChloroquineAIDS Research and Human Retroviruses, 1990